268 related articles for article (PubMed ID: 23673306)
21. And next… Adnexa: Ulerythema ophryogenes and keratosis pilaris.
Coelho De Sousa V; Pinheiro R; Cunha N; Lencastre A; Cabete J
Eur J Dermatol; 2018 Aug; 28(4):566-567. PubMed ID: 30396871
[No Abstract] [Full Text] [Related]
22. Noonan syndrome with multiple lentigines and prominent keratosis pilaris.
Fernández-Canga P; Vázquez-Osorio I; Álvarez-Cuesta CC; Rodríguez-Díaz E
J Dtsch Dermatol Ges; 2019 Jul; 17(7):749-751. PubMed ID: 31210391
[No Abstract] [Full Text] [Related]
23. Clinical manifestations in patients with SOS1 mutations range from Noonan syndrome to CFC syndrome.
Narumi Y; Aoki Y; Niihori T; Sakurai M; Cavé H; Verloes A; Nishio K; Ohashi H; Kurosawa K; Okamoto N; Kawame H; Mizuno S; Kondoh T; Addor MC; Coeslier-Dieux A; Vincent-Delorme C; Tabayashi K; Aoki M; Kobayashi T; Guliyeva A; Kure S; Matsubara Y
J Hum Genet; 2008; 53(9):834-841. PubMed ID: 18651097
[TBL] [Abstract][Full Text] [Related]
24. Keratosis pilaris (ulerythema ophryogenes).
GROSS P
AMA Arch Derm Syphilol; 1952 Nov; 66(5):642-3. PubMed ID: 12996047
[No Abstract] [Full Text] [Related]
25. [Keratosis pilaris and keratosis pilaris atrophicans faciei].
Arnold AW; Buechner SA
J Dtsch Dermatol Ges; 2006 Apr; 4(4):319-23. PubMed ID: 16638061
[TBL] [Abstract][Full Text] [Related]
26. Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations.
Longoni M; Moncini S; Cisternino M; Morella IM; Ferraiuolo S; Russo S; Mannarino S; Brazzelli V; Coi P; Zippel R; Venturin M; Riva P
Am J Med Genet A; 2010 Sep; 152A(9):2176-84. PubMed ID: 20683980
[TBL] [Abstract][Full Text] [Related]
27. [A case of Noonan Syndrome with coeliac disease due to SOS1 mutation].
Carcavilla Urquí A; Santomé Collazo JL; Barrio Castellanos R; Ezquieta Zubicaray B
Med Clin (Barc); 2011 Nov; 137(14):666-7. PubMed ID: 21524768
[No Abstract] [Full Text] [Related]
28. Folliculitis decalvans, or ulerythema ophryogenes?
WHITTLE CH
Br J Dermatol Syph; 1946; 58():29. PubMed ID: 21015902
[No Abstract] [Full Text] [Related]
29. Dermatological manifestations, management, and care in RASopathies.
Kavamura MI; Leoni C; Neri G
Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):452-458. PubMed ID: 36541891
[TBL] [Abstract][Full Text] [Related]
30. [Tuberous xanthomatosis, ulerythema ophryogenes and keratosis pilaris; pathogenic considerations].
ZELCER I
Sem Med; 1949 Nov; 56(45):876-8. PubMed ID: 15401650
[No Abstract] [Full Text] [Related]
31. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
Nava C; Hanna N; Michot C; Pereira S; Pouvreau N; Niihori T; Aoki Y; Matsubara Y; Arveiler B; Lacombe D; Pasmant E; Parfait B; Baumann C; Héron D; Sigaudy S; Toutain A; Rio M; Goldenberg A; Leheup B; Verloes A; Cavé H
J Med Genet; 2007 Dec; 44(12):763-71. PubMed ID: 17704260
[TBL] [Abstract][Full Text] [Related]
32. SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome.
Hanna N; Parfait B; Talaat IM; Vidaud M; Elsedfy HH
Clin Genet; 2009 Jun; 75(6):568-71. PubMed ID: 19438935
[TBL] [Abstract][Full Text] [Related]
33. [REPORT OF A CASE AND THERAPY OF ULERYTHEMA OPHRYOGENES].
ANTONEV AA; LOPUKHOVA KA; RABEN AS
Vestn Dermatol Venerol; 1964 Sep; 38():76-7. PubMed ID: 14248119
[No Abstract] [Full Text] [Related]
34. Keratosis Pilaris and its Subtypes: Associations, New Molecular and Pharmacologic Etiologies, and Therapeutic Options.
Wang JF; Orlow SJ
Am J Clin Dermatol; 2018 Oct; 19(5):733-757. PubMed ID: 30043128
[TBL] [Abstract][Full Text] [Related]
35. Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
Roberts AE; Araki T; Swanson KD; Montgomery KT; Schiripo TA; Joshi VA; Li L; Yassin Y; Tamburino AM; Neel BG; Kucherlapati RS
Nat Genet; 2007 Jan; 39(1):70-4. PubMed ID: 17143285
[TBL] [Abstract][Full Text] [Related]
36. Variable phenotypic expression in a large Noonan syndrome family segregating a novel SOS1 mutation.
van Trier DC; Rinne T; Noordam K; Draaisma JM; van der Burgt I
Am J Med Genet A; 2017 Nov; 173(11):2968-2972. PubMed ID: 28884940
[TBL] [Abstract][Full Text] [Related]
37. [Ulerythema ophryogenes and folliculitis ulerythematosa reticulata].
Azambuja R; Proença NG; Cardoso WV
Hautarzt; 1987 Jul; 38(7):411-3. PubMed ID: 3654209
[TBL] [Abstract][Full Text] [Related]
38. Ulerythema ophryogenes (Unna-Taenzer).
ZAKON SJ; GOLDBERG AL
AMA Arch Derm Syphilol; 1951 Dec; 64(6):785-7. PubMed ID: 14867921
[No Abstract] [Full Text] [Related]
39. Widespread keratosis pilaris in a patient with Noonan syndrome with multiple lentigines.
Purnak S; Topçu V; Çavdarlı B; Kadan E; Yalçın B
Int J Dermatol; 2018 Nov; 57(11):e140-e141. PubMed ID: 30152106
[No Abstract] [Full Text] [Related]
40. Dermatological manifestations in cardiofaciocutaneous syndrome: a prospective multicentric study of 45 mutation-positive patients.
Bessis D; Morice-Picard F; Bourrat E; Abadie C; Aouinti S; Baumann C; Best M; Bursztejn AC; Capri Y; Chiaverini C; Coubes C; Giuliano F; Hadj-Rabia S; Jacquemont ML; Lacombe D; Lyonnet S; Mallet S; Mazereeuw-Hautier J; Miquel J; Molinari N; Parfait B; Pernet C; Philip N; Pinson L; Pouvreau N; Vial Y; Sarda P; Sigaudy S; Verloes A; Cavé H; Geneviève D
Br J Dermatol; 2019 Jan; 180(1):172-180. PubMed ID: 30141192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
